Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Northwest Biotherapeutics Inc NWBO

Healthcare Biotechnology
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor... see more

Recent & Breaking News (OTCQB:NWBO)

TrendingWallStreet.com Releases Trend Research on NNRX, NWBO, FMCC, and IPCI

Accesswire November 21, 2013

SGOC, UNIS, AEZS and NWBO added to NASDAQ Active Stock Watch List at GSR

Accesswire November 20, 2013

Northwest Biotherapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants

PR Newswire November 20, 2013

TrendingWallStreet.com Releases Market Coverage on SVU, PGLO, AMZG, and NWBO

Accesswire November 19, 2013

OXBT, HZNP, PPHM and NWBO added to NASDAQ Healthcare Stock Watch List at GSR

Accesswire November 11, 2013

NW Bio's DCVax Featured On Fox News And Fox Business News

PR Newswire November 8, 2013

NW Bio Activates Second Site in DCVax-Direct Phase I/II Trial

PR Newswire September 24, 2013

German Regulator Authorizes NW Bio's Phase III GBM Trial To Open

PR Newswire September 17, 2013

NW Bio's Patent Portfolio Further Expanded With Manufacturing Automation Patent

PR Newswire September 10, 2013

Northwest Biotherapeutics Announces Registered Direct Offering

PR Newswire August 9, 2013

NW Bio Receives Regulatory Decision That Will Enable Its Phase III Brain Cancer Trial To Proceed In Germany

PR Newswire August 9, 2013

RedChip TV Announces Lineup for This Week's Show on Fox Business

Globe Newswire August 1, 2013

NW Bio Announces Above-Market Conversion of its $11.6 Million Debt to Its Manufacturer, Cognate Bioservices

PR Newswire July 31, 2013

16 Small-Cap Companies Scheduled to Present Today at RedChip Emerging Growth Showcase

Globe Newswire June 27, 2013

Hear From 30 Small-Cap Company Executives at the RedChip Emerging Growth Showcase on June 26-27

Globe Newswire June 24, 2013

RedChip TV Announces Guest Lineup for This Week's "RedChip Money Report"

Globe Newswire June 13, 2013

NW Bio Has Initiated Its DCVax®-Direct Phase I/II Trial For All Solid Tumor Cancers

PR Newswire June 13, 2013

NW Bio's Dr. Marnix Bosch To Present At Brain Tumor Biotech Summit In New York

PR Newswire June 6, 2013

NW Bio Added To The MSCI Global MicroCap Index

PR Newswire June 3, 2013

NW Bio To Present Company Highlights At The Marcum MicroCap Conference In New York

PR Newswire May 28, 2013